Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers
Sponsor: Il-Yang Pharm. Co., Ltd.
Summary
A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers
Official title: A Randomized, Double-blinded, Partial-open, Placebo/Active-controlled, Single/Multiple Dosing, Dose Escalation Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Characteristics of IY-828026 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2026-03-23
Completion Date
2027-06
Last Updated
2026-03-27
Healthy Volunteers
Yes
Conditions
Interventions
IY-828026
IY-828026
Placebo
Placebo comparator
IY-828026A
Active comparator
IY-828026B
Active comparator
Locations (1)
Seoul National University Hospital
Seoul, South Korea